Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenues	$ 10,736	$ 21,538
Cost of revenues	6,583	12,782
Gross profit	4,153	8,756
Operating expenses:
General and administrative	8,866	10,276
Sales and marketing	3,353	11,631
Research and development	2,890	8,545
Total operating expenses	15,109	30,452
Operating loss	(10,956)	(21,696)
Other income (expense):
Interest expense, net	(2,812)	(226)
Common stock warrant liability adjustment	1,912	(6,876)
Other income (expense), net	(11)	47
Total other income (expense), net	(911)	(7,055)
Loss before income tax provision	(11,867)	(28,751)
Income tax provision	0	(7)
Net loss and comprehensive loss	(11,867)	(28,758)
Accretion on Series A convertible preferred stock	(653)	0
Net loss attributable to common stockholders	(12,520)	(28,758)
Net loss attributable to common stockholders	$ (12,520)	$ (28,758)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.11)	$ (0.26)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.11)	$ (0.26)
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares)	113,545,429	110,384,313
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares)	113,545,429	110,384,313